Hyperprolactinaemia caused by antipsychotic drugs: Endocrine antipsychotic side effects must be systematically assessed [5] (multiple letters)

British Medical Journal

Volumn 324, Issue 7348, 2002, Pages 1278-1279

  Howes, Oliver ^a   Smith, Shubulade ^a   Winning, Sally ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR;

BONE DENSITY; HUMAN; HYPERPROLACTINEMIA; HYPOGONADISM; LETTER; MORBIDITY; OSTEOPENIA; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; CHEMICALLY INDUCED DISORDER; FEMALE; MALE; NOTE; OSTEOPOROSIS;

ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; HYPERPROLACTINEMIA; HYPOGONADISM; MALE; OSTEOPOROSIS;

EID: 0037172328     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (0)